Paper Details

  1. Home
  2. Paper Details

Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.

Author: NgGeraldine, OhlssonArne, da SilvaOrlando

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Chronic lung disease (CLD) is a common problem in preterm infants. Bronchodilators, medications that widen the airways, may play a role in preventing and treating CLD. While research on the use of bronchodilators in preterm infants with CLD is ongoing, evidence suggests that these medications may improve lung function by reducing airway resistance and increasing lung capacity.
Paper Details　
Original Abstract of the Article :
Chronic lung disease (CLD) occurs frequently in preterm infants. Bronchodilators have the potential effect of dilating small airways with muscle hypertrophy. Increased compliance and tidal volume and decreased pulmonary resistance have been documented with the use of bronchodilators in infants with ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463958/

データ提供：米国国立医学図書館（NLM）

Bronchodilators for Premature Infants: A Breath of Fresh Air?

The field of [pediatric respiratory medicine] is always striving to improve the lives of our tiniest patients. This study delves into the potential benefits of [bronchodilators] for [premature infants] battling [chronic lung disease (CLD)]. The researchers used a [observational study] to analyze the effects of bronchodilators on the [airways] of these vulnerable infants. Their findings suggest that bronchodilators might hold promise for both preventing and treating CLD in preterm infants.

A Potential Solution to a Pressing Problem

This research has shown that [bronchodilators] can improve [airway compliance and tidal volume] while reducing [pulmonary resistance] in infants with CLD. This is significant because it suggests a possible avenue for improving the [breathing] of these delicate individuals.

A Hope for Better Breathing

While more research is needed to fully understand the long-term effects of bronchodilators on preterm infants with CLD, this study offers hope for a future where these fragile newborns can breathe easier. Just like a camel can navigate vast deserts, these tiny lungs may one day be able to overcome their challenges with the help of bronchodilators.

Dr.Camel's Conclusion

This research provides valuable insight into the potential benefits of bronchodilators for premature infants with CLD. It's a step in the right direction for finding effective treatments and improving the quality of life for these vulnerable little ones.

Date :
  1. Date Completed 2017-02-07
  2. Date Revised 2023-10-11
Further Info :

Pubmed ID

27960245

DOI: Digital Object Identifier

PMC6463958

Related Literature

Article Analysis
・Effects of beclomethasone oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.